CHF10067 starting dose -- 1000mg
Idiopathic Pulmonary Fibrosis
Clinical trials
1
Developer
Chiesi Farmaceutici S.p.A.
Overview
CHF10067 starting dose -- 1000mg is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.
CHF10067 starting dose -- 1000mg clinical trials
Explore related
Medical disclaimer. This page summarizes research about CHF10067 starting dose -- 1000mg for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.